USFDA inspection: Laurus Labs arm gets 5 observations for AP facility

Published On 2023-12-13 05:48 GMT   |   Update On 2023-12-13 12:17 GMT
Advertisement

Hyderabad: Laurus Synthesis Private Limited (LSPL), a wholly owned subsidiary of Laurus Labs, has received a Form 483 with five observations from the United States Food and Drug Administration (USFDA) for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh.

The inspection was conducted from 4th December, 2023 to 12th December, 2023.

"We have been issued a Form 483 with five observations, and the Company will address the observations within stipulated timelines," the Company stated in a BSE filing.

Advertisement

An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. 

Read also: Laurus Labs, IIT Kanpur ink pact for novel gene therapy assets

Medical Dialogues team had earlier reported that the USFDA had concluded a PreApproval Inspection (PAI) with one observation at the manufacturing facility of Laurus Labs at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh.

Read also: Laurus Labs gets 1 USFDA observation for Visakhapatnam facility

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News